Trials / Unknown
UnknownNCT02197611
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. The Haemo-Adhaesione Questionnaire
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Universidad de Murcia · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Research project for the development, construction and validation of a questionnaire of adherence to treatment in adult patients with hemophilia. It aims to build a scale according to five relevant dimensions of adherence to treatment: 1) physician-patient relationship, 2) knowledge of the disease, 3) previous bleeding problems, 4) knowledge of future consequences and difficulties, and 5) benefits of treatment.
Detailed description
* Descriptive study for the construction of a multidimensional scale of adherence to treatment in adult patients with hemophilia. * Validation of a scale specific measure for patients with hemophilia that includes 5 dimensions that may affect adherence to treatment: a) the doctor-patient, b) regarding knowledge of the disease, c) the previous hemorrhages, d) knowledge future sequels, e) difficulties with treatment. * Statistical and psychometric analysis of the adherence questionnaire for adult patients with hemophilia. * Description of the theoretical framework that justifies the completion of the questionnaire, and the choice of the dimensions and items that make up the measurement scale. * The questionnaire obtained in this project will identify the actual degree of patient adherence to multidisciplinary treatment, taking as gold standard, compliance with pharmacological treatment (the difference between the treatment prescribed and consumed).
Conditions
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-01-01
- Completion
- 2016-05-01
- First posted
- 2014-07-22
- Last updated
- 2015-10-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02197611. Inclusion in this directory is not an endorsement.